MLS Capital Fund II LP - 29 May 2023 Form 3 Insider Report for GreenLight Biosciences Holdings, PBC

Role: Other*
Signature: MLS Capital Fund II, L.P. By: MLSCF II (GP) (Labuan), LLP Its: General Partner By: /s/ Ganesh Kishore Title: Manager
Issuer symbol: N/A
Transactions as of: 29 May 2023
Net transactions value: $0
Form type: 3
Filing time: 26 Jul 2023, 20:34:48 UTC
Next filing: 26 Jul 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	GRNA	Common Stock, par value $0.0001 per share						5,818,575	29 May 2023	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

The Reporting Person filed a Statement on Schedule 13D with the Securities and Exchange Commission on June 6, 2023, with respect to the shares reported herein. The Reporting Person may be deemed to be members of a "group" (within the meaning of Section 13(d)(3) of the Securities Exchange Act of 1934 of persons that, in the aggregate, beneficially owned more than 10% of the Issuer's Common Stock. The filing of this Form 3 shall not be construed as an admission that the Reporting Person was a beneficial owner of more than 10% of any class of securities of the Issuer for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose.